Medicare Enrolled
Dr. Andrew Kwa, M.D.
Cardiovascular Disease · San Jose, CA
Practice pattern: Remote & Electrophysiology
— Practice combining remote and electrophysiology services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kwa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kwa?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kwa
Dr. Andrew Kwa is a cardiovascular disease specialist in San Jose, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kwa performed 5,468 Medicare services across 3,102 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kwa received a total of $121,366 from 60 pharmaceutical and/or device companies across 1185 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kwa is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 16% volume in CA
$121,366 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,468
Medicare services
Top 16% in CA for cardiovascular disease
3,102
Unique beneficiaries
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~288 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
846 | $112 | $200 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
472 | $163 | $250 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
454 | $32 | $45 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
322 | $200 | $975 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
292 | $23 | $50 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
284 | $7 | $61 |
| ECG, 1-3 leads with physician review A simple electrocardiogram recording using one to three leads. A physician reviews the results. |
268 | $6 | $20 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
264 | $41 | $75 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
224 | $78 | $175 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
215 | $24 | $65 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
209 | $110 | $160 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
183 | $26 | $55 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
171 | $13 | $100 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
166 | $23 | $65 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
118 | $63 | $325 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
112 | $410 | $1,241 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
111 | $135 | $325 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
109 | $23 | $40 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
109 | $948 | $1,500 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
92 | $191 | $385 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
77 | $156 | $300 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
59 | $68 | $400 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
50 | $11 | $50 |
| New patient office visit, complex (60-74 min) | 44 | $197 | $400 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
37 | $32 | $100 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
36 | $233 | $825 |
| Cardiac catheterization | 34 | $189 | $900 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
26 | $155 | $325 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
26 | $22 | $45 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
23 | $13 | $50 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
22 | $78 | $125 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
13 | $12 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.9% high complexity
14.9% medium
70.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$121,366
Total received (2018-2024)
Avg $17,338/year across 7 years
Top 6% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
1,185
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$77,281 (63.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$43,257 (35.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$828 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,237
2023
$8,367
2022
$12,210
2021
$12,347
2020
$8,137
2019
$35,359
2018
$36,708
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$2,584
E.R. Squibb & Sons, L.L.C.
$2,013
Novartis Pharmaceuticals Corporation
$596
AstraZeneca Pharmaceuticals LP
$470
ShockWave Medical, Inc
$316
Merck Sharp & Dohme LLC
$275
Amgen Inc.
$194
HEARTFLOW, INC.
$185
Recor Medical Inc
$183
Medtronic, Inc.
$173
Edwards Lifesciences Corporation
$153
PFIZER INC.
$118
ASAHI INTECC USA, INC.
$111
Philips North America LLC
$104
Kiniksa Pharmaceuticals International, plc
$100
Janssen Pharmaceuticals, Inc
$100
SANOFI-AVENTIS U.S. LLC
$86
Boston Scientific Corporation
$72
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$66
Actelion Pharmaceuticals US, Inc.
$63
Novo Nordisk Inc
$59
Esperion Therapeutics, Inc.
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
Bayer Healthcare Pharmaceuticals Inc.
$44
BIOTRONIK INC.
$19
Baxter Healthcare
$19
Lexicon Pharmaceuticals, Inc.
$19
Kestra Medical Technology Services, Inc.
$17
Top 3 companies account for 63.1% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$41,748
E.R. Squibb & Sons, L.L.C.
$22,251
PFIZER INC.
$15,145
Abbott Laboratories
$9,241
BIOTRONIK INC.
$4,801
Cardiovascular Systems Inc.
$4,217
Philips Electronics North America Corporation
$2,889
Boston Scientific Corporation
$2,243
Novartis Pharmaceuticals Corporation
$1,936
Medtronic Vascular, Inc.
$1,417
Janssen Pharmaceuticals, Inc
$1,308
AstraZeneca Pharmaceuticals LP
$1,261
Inari Medical, Inc.
$1,179
ShockWave Medical, Inc
$949
Merck Sharp & Dohme LLC
$840
Medtronic, Inc.
$761
Penumbra, Inc.
$752
BOSTON SCIENTIFIC CORPORATION
$679
Amarin Pharma Inc.
$563
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$526
Actelion Pharmaceuticals US, Inc.
$466
Bardy Diagnostics, Inc.
$420
ABIOMED
$407
Lundbeck LLC
$402
Esperion Therapeutics, Inc.
$394
ASAHI INTECC USA, INC.
$350
SANOFI-AVENTIS U.S. LLC
$321
Kowa Pharmaceuticals America, Inc.
$315
Shockwave Medical, Inc
$306
Regeneron Healthcare Solutions, Inc.
$286
Bard Peripheral Vascular, Inc.
$224
Chiesi USA, Inc.
$222
Kiniksa Pharmaceuticals, Ltd.
$185
HEARTFLOW, INC.
$185
Edwards Lifesciences Corporation
$183
Recor Medical Inc
$183
AngioDynamics, Inc.
$165
Merck Sharp & Dohme Corporation
$142
Medicure Pharma Inc.
$136
Biosense Webster, Inc.
$125
Cook Medical LLC
$124
Gilead Sciences, Inc.
$114
Terumo Medical Corporation
$113
Philips North America LLC
$104
ATRICURE, INC.
$102
Kiniksa Pharmaceuticals International, plc
$100
Allergan Inc.
$84
Alnylam Pharmaceuticals Inc.
$71
Boehringer Ingelheim Pharmaceuticals, Inc.
$67
Astellas Pharma US Inc
$59
Novo Nordisk Inc
$59
Baxter Healthcare
$50
Bayer Healthcare Pharmaceuticals Inc.
$44
iRhythm Technologies, Inc.
$38
Akcea Therapeutics, Inc.
$28
HeartFlow, Inc.
$20
Lexicon Pharmaceuticals, Inc.
$19
Kestra Medical Technology Services, Inc.
$17
Ethicon US, LLC
$16
Electromed, Inc.
$13
Top 3 companies account for 65.2% of all-time payments
Associated products mentioned in payments ›
(4066) Tack Endo Sys ATK · (5027) Intact Vascular Und · (5044) MCOT · (5050) Ext Holter · (6366) Sync · (6571) Eagle Eye · (6574) Coronary Other · (6575) Coronary Undivided · (7999) SRC Undivided · (8333) IGT D Coronary · (9266) ELCA · (9267) AngioSculpt CV RX · (BR0) Coronary Atherectomy · (P88) IGT Devices FM · 3F · ANGIO-SEAL · ASAHI PTCA Guide Wire · ATRICLIP LAA EXCLUSION SYSTEM · AURYON LASER SYSTEM 100-120 VAC · AVVIGO · AVVIGO Guidance System · AZURE XT DR MRI SURESCAN · Acticor · Arcalyst · Assure WCD · Assurity Pacemaker · Azure · BIOFLO · BIOMONITOR · BOSENTAN TABLETS · BRILINTA · BYSTOLIC · BioMonitor · CAMZYOS · CARDIOMEMS · CHANTIX · COMET · CONFIRM RX · COREVALVE EVOLUT R · CROSSBOSS · CardioMEMS HF System · CareLink · Carnation Ambulatory Monitor · Carto 3 System · Confirm Rx · Cook Medical AAA · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DIAMONDBACK CORONARY · DIAMONDBACK PERIPHERAL · Diamondback Peripheral · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMERGE · ENTRESTO · EVKEEZA · Edora · Edora 8 DR-T · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FORTIFY ASSURA · Fortify Assura · GALLANT · GENERAL STENTS · GENERAL THERAPIES · GENERAL VASCULAR ACCESS · GENERAL STENTS · GENERAL - STENTS · GENERAL - THERAPIES · GENERAL STENTS · GENERAL VASCULAR INTERVENTION · GUIDEZILLA · General - Therapies · HMG-CoA reductase inhibitor. · HORNET · HeartMate · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · IGT D Coronary · IGT D Peripheral · IGT Devices Und · IGT_D Coronary · IGT_D Therapy · IN.PACT Admiral · Impella · Indigo System · JARDIANCE · JETI · JOT DX · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LINQ II · Letairis · Lexiscan · LifeVest · Livalo · Lutonix Drug Coated Balloon · MERLIN@HOME · MITRACLIP · MULTAQ · MetaCross · Micra · Mitra Clip system · MitraClip System · NAVICROSS · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTIS · PARADISE RENAL DENERVATION SYSTEM · PERIPHERAL VASCULAR · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Penumbra System · Peripheral Orbital Atherectomy System · Pulsar · ROTABLATOR · Repatha · Resolute · Reveal LINQ · Rivacor · Rybelsus · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SMARTVEST · STINGRAY · STRATAFIX · SYNERGY · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TEGSEDI · TurboHawk · UPTRAVI · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · Vascular Lithotripsy · WATCHMAN · WATCHMAN FLX · XARELTO · XIENCE SIERRA · XIENCE SKYPOINT · Xience Alpine coronary stent system · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (64%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
205
Per 100K population
10.8
County median income
$159,674
Nearest hospital
GOOD SAMARITAN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kwa is a remote & electrophysiology specialist, with above-average Medicare volume (top 16% in CA), with speaking/promotional industry engagement in the top 6% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kwa experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kwa performed 846 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kwa receive payments from pharmaceutical companies?
Yes. Dr. Kwa received a total of $121,366 from 60 companies across 1,185 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kwa's costs compare to other cardiologists in San Jose?
Dr. Kwa's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kwa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in San Jose
Browse cardiologists in San Jose ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology